As a world leading cancer care company they aim to improve the health and quality of life for every person with cancer - today, now, when it counts. Their vision is to help people with cancer get the most of every day. As one of the world's leading cancer care companies, their goal is to make everything they do, from the products they choose to license to the quality standards they apply to manufacturing, count towards improving the lives of people with cancer.

AMRI (Albany Molecular Research Inc.) is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded over 27 years ago, AMRI operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. AMRI has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Co., Takeda, Genentech, Bristol-Myers Squibb Co. and GE.

Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the use of nausea and vomiting; APD209, which is for the use of cancer cachexia; and APD421, an intravenous formulation for the use of prevention and treatment of nausea and vomiting. The company also concentrates its discovery efforts in cancer related fatigue, cancer cachexia, and xerostomia. Acacia Pharma Ltd. was incorporated in 2006 and is based in Cambridge, United Kingdom.

Nanoform Therapeutics is develops new generation of Bio-Pharmaceutical developmental or marketed drugs to “first-in-man” demonstration of improved clinical utility when compared to the original versions.

Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.

InnoPharma, Inc. provides pharma drugs. The firm is a developer of sterile generic and specialty pharmaceutical products. It works with manufacturing and clinical research organizations worldwide for commercialization of its developed products. The company was founded by Navneet Puri and Sriram J. Ramanathan in 2005 and is headquartered in Piscataway, NJ.

Luxena Pharmaceuticals, Inc. is an American private company. The firm develops and manufactures pharmaceutical formulation.

Ocera is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need. Ocera's HE clinical development efforts include a recently completed Phase 2b clinical trial, STOP-HE, which evaluated the safety and efficacy of intravenously-administered OCR-002 in resolving neurocognitive symptoms of acute HE in hospitalized patients with elevated ammonia. Ocera is preparing to meet with the FDA later this year to review the IV program and discuss potential development paths forward.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Somerset Therapeutics, a New Jersey based specialty pharmaceutical company that develops and markets sterile injectable and ophthalmic drugs for the U.S. marketplace, and the business of its India based affiliate Wintac Limited, which operates as Somerset Therapeutics' contract developer and manufacturer.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

XW Laboratories is an Asia-Pacific biopharmaceutical company dedicated to discovering and developing transformational medicines that will markedly improve the quality of life in patients suffering from neurological disorders. Founded in 2014, XW Laboratories has developed 3 unique drug R&D platforms that not only allow us to improve upon existing medication through approaches such as prodrug and functional group switch, but also be at the forefront of medicinal technology in immunoneurology through the application of their mitochondria-targeting platform.

Zhejiang Xina Pharmaceutical Co., Ltd., established on 2019-03-28, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Health Consulting Services(Does not include medical services);data processing services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Verisfield (UK) Ltd. is a private company headquartered in London, UK, focused on pharmaceutical preparations. It was founded in 2000.

Beijing Xinghao Yingsheng Pharmaceutical Co., Ltd., established on 2014-07-29, The scope of business includes the production of pharmaceuticals(Restricted manufacturing of chemical preparations);sell food.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,production of medicines(Restricted manufacturing of chemical preparations)and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Jinan Bangwen Pharmaceutical Technology Co., Ltd., established on 2015-02-15, Business scope includes medical technology development;Chinese medicine products,Healthy food,Technology development of washing products,Technical Consulting and Technical Services;translation service;office services(Does not include engraved seal);data processing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Datong Hemp Biotechnology Research Institute (Qingdao) Co., Ltd., established on 2020-05-19, Business scope includes general items:Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;internet sales(Except for products that require a license for sale);General merchandise sales;Sales of hygiene products and single-use medical products;daily mask(non-medical)Sales;daily mask(non-medical)Production;Personal Hygiene Sales;Cosmetics Wholesale;Cosmetics Retail;Daily miscellaneous goods sales;Daily necessities sales;Maternal and baby products manufacturing;Maternal and baby products sales;food business(Selling prepackaged food);Food Internet Sales(Selling prepackaged food);Clothing and apparel wholesale;Clothing and apparel retail;needle textile sales;Sales of labor protection products;Pet food and supplies retail;Pet Food and Supplies Wholesale;Manufacture of knitted or crocheted fabrics and articles thereof;Household Goods Sales;Household Goods Manufacturing;Sales of clothing accessories;cotton,hemp sales;Paper Products Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Food Internet Sales;food business;food business(sell bulk food);Health food sales;Cosmetic production;liquor business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK.